V
ISSUER//CIK 0001003929
VIA Pharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 10-K1.3 MBVIA Pharmaceuticals, Inc.Mar 24, 3:57 PM ET·0000950123-11-028637
- 8-K54.7 KBVIA Pharmaceuticals, Inc.Jan 18, 5:08 PM ET·0000950123-11-003476
- 8-K12.5 KBVIA Pharmaceuticals, Inc.Nov 22, 2:53 PM ET·0000950123-10-107740
- SC 13D/A87.8 KBVIA Pharmaceuticals, Inc.Nov 17, 4:46 PM ET·0000950123-10-106676
- 412.2 KBVIA Pharmaceuticals, Inc.Nov 17, 3:34 PM ET·0001209191-10-055481
- 10-Q1.0 MBVIA Pharmaceuticals, Inc.Nov 15, 4:29 PM ET·0000950123-10-105728
- 8-K37.1 KBVIA Pharmaceuticals, Inc.Nov 4, 2:39 PM ET·0000950123-10-100806
- 8-K11.4 KBVIA Pharmaceuticals, Inc.Sep 29, 3:46 PM ET·0000950123-10-090045
- 10-Q671.1 KBVIA Pharmaceuticals, Inc.Aug 16, 2:00 PM ET·0000950123-10-077890
- 8-K12.9 KBVIA Pharmaceuticals, Inc.Jul 28, 4:19 PM ET·0000950123-10-069066
Insiders
10- ARIES FINANCIAL SERVICES INCInsider
- ARIES TRUSTInsider
- ATWOOD ROBERT TDirector, CFO, Executive VP
- Bagnall MarkDirector
- BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP10% Owner
- BAY CITY CAPITAL LLC10% Owner
- BOSTON SCIENTIFIC CORP10% Owner
- CALLICUTT JACK WVP-Finance&Admin, Chf Acct Off
- CHIANG YAWEN LSVP - Chief Scientific Officer
- Cohen Lawrence KennethDirector, CEO and President
Tickers
No tickers on record
Addresses
business
750 BATTERY STREET SUITE 330
SAN FRANCISCO, CA, 94111
mailing
750 BATTERY STREET SUITE 330
SAN FRANCISCO, CA, 94111
Former Names
- CORAUTUS GENETICS INC2007-06-20
- GENSTAR THERAPEUTICS CORP2002-12-19
- UROGEN CORP2000-02-14